Epidemiology, pathogenesis and management of hepatitis D: update and challenges ahead (Q37669159)

21 August 2017

1 reference

title

Epidemiology, pathogenesis and management of hepatitis D: update and challenges ahead (English)

1 reference

21 August 2017

0 references

1 reference

1 reference

2

Michael P Manns

1 reference

21 August 2017

1

Heiner Wedemeyer

1 reference

PubMed ID

20051970

21 August 2017

language of work or name

English

0 references

publication date

1 January 2010

1 reference

Nature Reviews Gastroenterology & Hepatology

21 August 2017

1 reference

21 August 2017

7

1 reference

21 August 2017

31-40

1 reference

21 August 2017

1

1 reference

https://scigraph.springernature.com/pub.10.1038/nrgastro.2009.205

21 August 2017

0 references

cites work

Immunofluorescence detection of new antigen-antibody system (delta/anti-delta) associated to hepatitis B virus in liver and in serum of HBsAg carriers

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.205

Incidence and significance of antibodies to delta antigen in hepatitis B virus infection

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.205

delta Agent: association of delta antigen with hepatitis B surface antigen and RNA in serum of delta-infected chimpanzees

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.205

31 March 2020

Hepatitis delta virus

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.205

Molecular phylogenetic analyses indicate a wide and ancient radiation of African hepatitis delta virus, suggesting a deltavirus genus of at least seven major clades

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.205

Prevalence and genetic diversity of hepatitis B and delta viruses in pregnant women in Gabon: molecular evidence that hepatitis delta virus clade 8 originates from and is endemic in central Africa

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.205

Genotypes and viremia of hepatitis B and D viruses are associated with outcomes of chronic hepatitis D patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.205

Intrafamilial transmission of hepatitis delta virus: molecular evidence.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.205

Hepatitis D virus infection--not a vanishing disease in Europe!

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.205

Chronic hepatitis D: a vanishing Disease? An Italian multicenter study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.205

Delta hepatitis: an update

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.205

Seropositivity for delta hepatitis in patients with chronic hepatitis B and liver cirrhosis in Turkey: a meta-analysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.205

High prevalence of dual or triple infection of hepatitis B, C, and delta viruses among patients with chronic liver disease in Mongolia.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.205

Socioepidemiological data on hepatitis delta in a German university clinic--increase in patients from Eastern Europe and the former Soviet Union

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.205

Acute hepatitis delta virus infection in Italy: incidence and risk factors after the introduction of the universal anti-hepatitis B vaccination campaign

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.205

Delta hepatitis in homosexual men in the United States

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.205

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.205

Hepatitis D virus infection in Illinois state facilities for the developmentally disabled. Epidemiology and clinical manifestations

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.205

HDV genotypes in the Western Brazilian Amazon region: A preliminary report.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.205

[Prevalence of hepatitis B and D serological markers in the Parakanã, Apyterewa Indian Reservation, Pará State, Brazil]

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.205

High prevalence of hepatitis B virus and hepatitis D virus in the western Brazilian Amazon.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.205

Characterization of hepatitis D virus genotype III among Yucpa Indians in Venezuela

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.205

Quantitative HBsAg and HDV-RNA levels in chronic delta hepatitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.205

Identification of novel HLA-A*0201-restricted CD8+ T-cell epitopes on hepatitis delta virus.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.205

Cytotoxic CD4 T cells in viral hepatitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.205

Hepatitis delta virus inhibits alpha interferon signaling

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.205

Longitudinal evaluation reveals a complex spectrum of virological profiles in hepatitis B virus/hepatitis C virus-coinfected patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.205

Role of hepatitis B, C, and D viruses in dual and triple infection: influence of viral genotypes and hepatitis B precore and basal core promoter mutations on viral replicative interference

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.205

Virologic and clinical expressions of reciprocal inhibitory effect of hepatitis B, C, and delta viruses in patients with chronic hepatitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.205

Smouldering hepatitis B virus replication in patients with chronic liver disease and hepatitis delta virus superinfection

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.205

Hepatitis delta virus proteins repress hepatitis B virus enhancers and activate the alpha/beta interferon-inducible MxA gene.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.205

Virological and clinical characteristics of delta hepatitis in Central Europe

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.205

EASL Clinical Practice Guidelines: management of chronic hepatitis B.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.205

Natural history: the importance of viral load, liver damage and HCC.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.205

Hepatitis B virus DNA levels and outcomes in chronic hepatitis B.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.205

Hepatitis D: thirty years after

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.205

Clearance of chronic HCV infection during acute delta hepatitis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.205

Treatment of chronic hepatitis delta with pegylated interferon-alpha2b

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.205

Treatment of chronic delta hepatitis with lamivudine vs lamivudine + interferon vs interferon

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.205

Longitudinal evaluation of viral interactions in treated HIV-hepatitis B co-infected patients with additional hepatitis C and D virus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.205

Non-invasive evaluation of liver fibrosis using transient elastography

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.205

Food intake increases liver stiffness in patients with chronic or resolved hepatitis C virus infection

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.205

The significance of infections with two types of viral hepatitis demonstrated by histologic features in chimpanzees.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.205

Hepatitis B virus (HBV)/hepatitis D virus (HDV) coinfection in outbreaks of acute hepatitis in the Peruvian Amazon basin: the roles of HDV genotype III and HBV genotype F.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.205

Infection with hepatitis A, B, C, and delta viruses among patients with acute hepatitis in Mongolia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.205

Influence of hepatitis delta virus infection on progression to cirrhosis in chronic hepatitis type B.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.205

Risk factors for hepatocellular carcinoma in Turkey

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.205

A 28-year study of the course of hepatitis Delta infection: a risk factor for cirrhosis and hepatocellular carcinoma.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.205

Impact of hepatitis D virus infection on the long-term outcomes of patients with hepatitis B virus and HIV coinfection in the era of highly active antiretroviral therapy: a matched cohort study.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.205

Famciclovir treatment of chronic hepatitis B in heart transplant recipients: a prospective trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.205

Famciclovir treatment of chronic delta hepatitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.205

Lamivudine-high dose interferon combination therapy for chronic hepatitis B patients co-infected with the hepatitis D virus.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.205

Lamivudine therapy in chronic delta hepatitis: a multicentre randomized-controlled pilot study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.205

Lamivudine for chronic delta hepatitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.205

Pegylated interferon alpha-2b as monotherapy or in combination with ribavirin in chronic hepatitis delta.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.205

Ribavirin treatment for chronic hepatitis D: a pilot study.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.205

Clevudine inhibits hepatitis delta virus viremia: a pilot study of chronically infected woodchucks.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.205

Long-term therapy with clevudine for chronic hepatitis B can be associated with myopathy characterized by depletion of mitochondrial DNA.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.205

Molecular anatomy and pathophysiologic implications of drug resistance in hepatitis B virus infection

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.205

Failure of the lamivudine-resistant rtM204I hepatitis B virus mutants to efficiently support hepatitis delta virus secretion

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.205

Analysis of the cytosolic domains of the hepatitis B virus envelope proteins for their function in viral particle assembly and infectivity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.205

Treatment of chronic delta hepatitis with alpha-2 recombinant interferon

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.205

Treatment of hepatitis D.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.205

Treatment of chronic hepatitis D with interferon alfa-2a

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.205

Long-term benefit of interferon alpha therapy of chronic hepatitis D: regression of advanced hepatic fibrosis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.205

Resolution of chronic delta hepatitis after 12 years of interferon alfa therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.205

Treating viral hepatitis C: efficacy, side effects, and complications

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.205

Efficacy of peginterferon alpha-2b in chronic hepatitis delta: Relevance of quantitative RT-PCR for follow-up

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.205

HBsAg level at time of liver transplantation determines HBsAg decrease and anti-HBs increase and affects HBV DNA decrease during early immunoglobulin administration

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.205

Hepatitis D viremia following orthotopic liver transplantation involves a typical HDV virion with a hepatitis B surface antigen envelope.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.205

Prophylaxis, diagnosis and therapy of hepatitis B virus (HBV) infection: the German guidelines for the management of HBV infection.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.205

In vivo antiviral efficacy of prenylation inhibitors against hepatitis delta virus.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.205

Delta hepatitis in Turkey: decreasing but not vanishing and still of concern

31 March 2020

1 reference

12 December 2020

Two-year interferon therapy with or without ribavirin in chronic delta hepatitis

1 reference

12 December 2020

Hepatitis D: virology, clinical and epidemiological aspects

1 reference

12 December 2020

Liver cirrhosis in HIV-infected patients: prevalence, aetiology and clinical outcome.

1 reference

12 December 2020

Does treatment of hepatitis B virus (HBV) infection reduce hepatitis delta virus (HDV) replication in HIV-HBV-HDV-coinfected patients?

1 reference

12 December 2020

A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C.

1 reference

12 December 2020

Quantitative analysis of hepatitis D virus RNA and hepatitis B surface antigen serum levels in chronic delta hepatitis improves treatment monitoring.

1 reference

12 December 2020

Prevalence and molecular diversity of hepatitis B virus and hepatitis delta virus in urban and rural populations in northern Gabon in central Africa

1 reference

12 December 2020

The increasing prevalence of hepatitis delta virus (HDV) infection in South London

1 reference

12 December 2020

Production of hepatitis delta virus and suppression of helper hepatitis B virus in a human hepatoma cell line

1 reference

12 December 2020

Review: hepatitis delta

1 reference

12 December 2020

A multicenter study of viral hepatitis in a United States hemophilic population

1 reference

12 December 2020

Human CD4+ T-cell response to hepatitis delta virus: identification of multiple epitopes and characterization of T-helper cytokine profiles.

1 reference

12 December 2020

A randomized controlled trial of a 12-month course of recombinant human interferon-alpha in chronic delta (type D) hepatitis: a multicenter Italian study

1 reference

12 December 2020

Recent high incidence of fulminant hepatitis in Samara, Russia: molecular analysis of prevailing hepatitis B and D virus strains.

1 reference

12 December 2020

HDV infection in the Western Pacific region

1 reference

12 December 2020

10.1038/NRGASTRO.2009.205

Identifiers

DOI

1 reference

21 August 2017

1 reference

PubMed ID

20051970